BCRX icon

BioCryst Pharmaceuticals

123 hedge funds and large institutions have $817M invested in BioCryst Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 40 reducing their positions, and 14 closing their positions.

Holders
123
Holders Change
+7
Holders Change %
+6.03%
% of All Funds
2.74%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
21
Increased
31
Reduced
40
Closed
14
Calls
$2.1M
Puts
$1.44M
Net Calls
+$657K
Net Calls Change
+$253K
Name Market Value Shares Shares
Change
Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$122M 15,103,081
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$99.3M 12,302,555 +52,394 +0.4%
RCM
3
RA Capital Management
Massachusetts
$86M 10,660,349 +1,425,657 +15%
BlackRock
4
BlackRock
New York
$71.4M 8,849,427 +79,571 +0.9%
GPP
5
Great Point Partners
Connecticut
$61.5M 7,622,256 -356,019 -4%
DM
6
Deerfield Management
New York
$55.8M 6,910,789
Vanguard Group
7
Vanguard Group
Pennsylvania
$47.4M 5,872,229 +74,000 +1%
Jennison Associates
8
Jennison Associates
New York
$30.7M 3,798,853 -51,150 -1%
VMI
9
VHCP Management II
New York
$26.2M 3,249,164
VMI
10
VHCP Management III
New York
$24.7M 3,061,091
Fidelity Investments
11
Fidelity Investments
Massachusetts
$24.1M 2,992,009 -761,794 -20%
State Street
12
State Street
Massachusetts
$22.6M 2,796,960 -598,741 -18%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$12.1M 1,499,482 -208,837 -12%
Northern Trust
14
Northern Trust
Illinois
$10.9M 1,350,616 -3,217 -0.2%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$9.91M 1,227,763 +108,785 +10%
EAM
16
Eventide Asset Management
Massachusetts
$8.45M 1,047,000
Invesco
17
Invesco
Georgia
$8.11M 1,004,725 +115,333 +13%
Millennium Management
18
Millennium Management
New York
$6.52M 808,027 -371,780 -32%
Citadel Advisors
19
Citadel Advisors
Florida
$5.81M 720,204 +665,917 +1,227%
RSCM
20
Rock Springs Capital Management
Maryland
$5.65M 700,000
Charles Schwab
21
Charles Schwab
California
$4.83M 597,822 -18,081 -3%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$4.38M 543,026 +122,201 +29%
TCIM
23
TIAA CREF Investment Management
New York
$4.1M 508,508 +3,402 +0.7%
GTC
24
Ghost Tree Capital
New York
$4.04M 500,000
DCM
25
DAFNA Capital Management
California
$3.75M 464,415 -187,671 -29%